Rayonier Inc. REIT Common Stock (RYN)
24.18
+0.00 (0.00%)
NYSE · Last Trade: Oct 16th, 5:31 AM EDT
Atlanta, GA – October 14, 2025 – In a move set to reshape the North American timber and wood products landscape, PotlatchDeltic Corporation (NASDAQ: PCH) announced today its definitive agreement to merge with Rayonier Inc. (NYSE: RYN) in an all-stock transaction. The news sent PotlatchDeltic shares soaring, reflecting investor optimism for the
Via MarketMinute · October 14, 2025
Rayonier Inc. and PotlatchDeltic Corp. have agreed to merge, creating a leading U.S. land resources owner and lumber manufacturer.
Via Benzinga · October 14, 2025
PotlatchDeltic, Rayonier To Merge In All-Stock Deal To Form US Land And Lumber Giantstocktwits.com
Via Stocktwits · October 14, 2025
Boise Cascade (NYSE: BCC), a leading manufacturer of wood products and wholesale distributor of building materials, has seen its stock price repeatedly breach new 12-month lows in early October 2025. This downturn, with shares hitting $72.15 on October 13, 2025, signals significant challenges within the broader timber and building
Via MarketMinute · October 13, 2025
Via Benzinga · April 5, 2025

Via Benzinga · February 5, 2025

For this week, we expect a slight pause in momentum, though nothing particularly dramatic.
Via Talk Markets · September 23, 2024

Rayonier agrees to sell its 77% stake in New Zealand joint venture for $710 million, aiming to reduce leverage and return capital to shareholders.
Via Benzinga · March 11, 2025

RYN stock results show that Rayonier missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 7, 2024

RYN stock results show that Rayonier beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 1, 2024

The stock market has gotten bumpier lately. These compelling REITs to buy can offer strong dividends to ride out the storm.
Via InvestorPlace · April 23, 2024

Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion.
Via Benzinga · January 31, 2024

Via Benzinga · December 22, 2023

Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.
Via Benzinga · November 1, 2023